News for REGENXBIO Inc. (RGNX)

Published at

Jun 5, 2025 8:31 PM

by benzinga.com

mixed

mixed

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Ciena (NYSE:CIEN), ChargePoint Hldgs (NYSE:CHPT)

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 0.1% points on Thursday. The Dow traded down 0.06% to 42,400.42 wh...

RGNX OMI NVDA CHPT-WT CHPT PVH CIEN 0KEQ.L

Read more →
Published at

Jun 5, 2025 4:34 PM

by benzinga.com

mixed

mixed

Dow Dips Over 100 Points; US Jobless Claims Increase - ChargePoint Hldgs (NYSE:CHPT), Liminatus Pharma (NASDAQ:LIMN)

U.S. stocks traded lower this morning, with the Dow Jones dipping more than 100 points on Thursday. The Dow traded down 0.33% to 42,287.54 while the NASDAQ fel...

RGNX NVDA CHPT-WT CHPT PVH 0KEQ.L

Read more →
Published at

May 20, 2025 12:00 AM

by gurufocus.com

positive

positive

REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

PR NewswireROCKVILLE, Md., May 19, 2025 $150 million secured at closing extends cash runway into early 2027REGENXBIO retains additional potential non-dilut

YI RGNX RCKT

Read more →
Published at

May 14, 2025 3:00 PM

by gurufocus.com

positive

positive

FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment

PR NewswirePARAMUS, N.J., May 14, 2025 PARAMUS, N.J., May 14, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (

YI RGNX NPPNY NPNKF 4516N.MX 4516.T

Read more →
Published at

May 13, 2025 1:07 PM

by seekingalpha.com

mixed

mixed

REGENXBIO Inc. (RGNX) Q1 2025 Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ETCompany ParticipantsPatrick Christmas - Chief Legal OfficerCurran...

RGNX MSCL.SN

Read more →
Published at

May 13, 2025 12:00 AM

by gurufocus.com

positive

positive

REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational Highlights

PR NewswireROCKVILLE, Md., May 12, 2025 RGX-202 in Duchenne muscular dystrophy on track for BLA submission mid-2026Pivotal trial more than half enrolled, w

YI RGNX

Read more →
Published at

May 6, 2025 3:00 PM

by gurufocus.com

mixed

mixed

REGENXBIO to Participate in Upcoming Investor Conferences

PR NewswireROCKVILLE, Md., May 6, 2025 ROCKVILLE, Md., May 6, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the

RGNX YI

Read more →
Published at

May 4, 2025 2:00 PM

by seekingalpha.com

mixed

mixed

Investing Groups Roundtable: Tariff Policy Impact - Part 3

Read about top market insights and strategies from experts in shipping, commodities, technology and biotech in this final instalment of the Investing Groups Roundtable.

TTD RGNX PPTA USAU

Read more →
Published at

Apr 21, 2025 3:20 PM

by gurufocus.com

positive

positive

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO) | LCTX Stock News

Lineage Cell Therapeutics (LCTX) to participate in Eyecelerator 2025 panel on novel drug delivery for glaucoma and retina. The event is sponsored by the

RGNX

Read more →
Published at

Mar 26, 2025 5:31 PM

by seekingalpha.com

neutral

neutral

5 Reasons To Buy Regenxbio Right Now (NASDAQ:RGNX)

Regenxbio Inc. is ranked a Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and major buyout potential. Click for more on RGNX stock.

RGNX

Read more →
Published at

Mar 26, 2025 12:07 PM

by benzinga.com

mixed

mixed

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Chewy (NYSE:CHWY), Bausch Health Companies (NYSE:BHC)

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday. Shares of Chewy, Inc. CHWY fell sharply in pre-market t...

PPTA.TO PPTA HUMA RGNX NYXH.BR NYXH NYXFF CHWY.MX CHWY BHCN.MX BHC.TO BHC

Read more →
Published at

Mar 23, 2025 12:18 PM

by seekingalpha.com

mixed

mixed

Wall Street Week Ahead

Stay updated with Wall Street's weekly highlights: key inflation data, CoreWeave IPO, and earnings reports. Insights on biotech trends & top stock picks.

RGNX NVDA PAYX LULU DLTR CTAS CNM SRPT

Read more →
Published at

Mar 19, 2025 4:00 PM

by gurufocus.com

mixed

mixed

REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY

PR NewswireROCKVILLE, Md., March 19, 2025 Positive biomarker data in patient aged 1-3 add to consistent, robust microdystrophin and transduction levels acr

RGNX YI

Read more →
Published at

Mar 18, 2025 11:32 PM

by gurufocus.com

mixed

mixed

Market Today: IBM and NVIDIA Collaborate on AI, Alphabet Acquires Wiz for $32B

Market Overview The stock market closed with losses across the board. Major indices ended the session with declines ranging from 0.6% to 1.7%. Despite the downt

SRPT SMCI RGNX NVDA GOOGL TSLA MU AFRM

Read more →
Published at

Mar 14, 2025 8:09 AM

by gurufocus.com

positive

positive

Regenxbio Inc (RGNX) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Resilience

Cash Equivalents and Marketable Securities: $245 million as of December 31, 2024, down from $314 million as of December 31, 2023.R&D Expenses: $209 million for

RGNX

Read more →
Published at

Mar 14, 2025 6:09 AM

by gurufocus.com

positive

positive

Q4 2024 Regenxbio Inc Earnings Call Transcript

Mar 13, 2025 / 08:30PM GMTOperator Welcome, everyone, to the fourth-quarter and year-end 2024 REGENXBIO earnings conference call. (Operator Instructions) Please

RGNX

Read more →
Published at

Mar 13, 2025 11:44 PM

by seekingalpha.com

mixed

mixed

REGENXBIO Inc. (RGNX) Q4 2024 Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ETCompany ParticipantsPatrick Christmas - Chief Legal OfficerCurran...

RGNX MSCL.SN

Read more →
Published at

Mar 13, 2025 11:25 PM

by gurufocus.com

neutral

neutral

Regenxbio Inc (RGNX) Q4 2024 Earnings: EPS Beats Estimates at -$1.01, Revenue Misses at $21.2 Million

Revenue: $21.2 million for Q4 2024, slightly below the estimated $23.75 million, reflecting a decrease from $22.2 million in Q4 2023.Earnings Per Share (EPS):

RGNX

Read more →
Published at

Mar 13, 2025 11:00 PM

by gurufocus.com

positive

positive

REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates

PR NewswireROCKVILLE, Md., March 13, 2025 Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential

YI RGNX FRGAP

Read more →
Published at

Mar 13, 2025 10:25 PM

by zacks.com

negative

negative

Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates

Regenxbio (RGNX) delivered earnings and revenue surprises of 20.47% and 7.36%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

RGNX

Read more →